Peripheral and central sites of action for A-85380 in the spinal nerve ligation model of neuropathic pain

Pain

Volumn 103, Issue 3, 2003, Pages 269-276

  Rueter, Lynne E ^a   Kohlhaas, Kathy L ^a   Curzon, Peter ^a   Surowy, Carol S ^a   Meyer, Michael D ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Chlorisondamine; Chung model; Dorsal root ganglion; Intraplantar; Nicotinic acetylcholine receptors; Pain

Indexed keywords

3 (2 AZETIDINYLMETHOXY)PYRIDINE; CHLORISONDAMINE; HEXAMETHONIUM; MECAMYLAMINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; DRUG INFUSION; DRUG MECHANISM; DRUG POTENCY; MALE; NERVE LIGATION; NEUROPATHIC PAIN; NOCICEPTIVE STIMULATION; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RAT; RECEPTIVE FIELD; RECEPTOR BLOCKING; SPINAL NERVE; THERMAL STIMULATION;

EID: 0037849869     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0304-3959(02)00455-4     Document Type: Article

References (36)

1. Attal N., Bouhassira D. Mechanisms of pain in peripheral neuropathy. Acta Neurol Scand. 173:(Suppl):1999;12-24.
2. Bannon A.W., Decker M.W., Holladay M.W., Curzon P., Donnelly-Roberts D., Puttfarcken P.S., Bitner R.S., Diaz A., Dickenson A.H., Porsolt R.D., Williams M., Arneric S.P. Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science. 279:1998;77-81.
3. Bian D., Ossipov M.H., Zhong C., Malan T.P. Jr, Porreca F. Tactile allodynia, but not thermal hyperalgesia, of the hindlimbs is blocked by spinal transection in rats with nerve injury. Neurosci Lett. 241:1998;79-82.
4. Bitner R.S., Nikkel A.L., Curzon P., Donnelly-Roberts D.L., Puttfarcken P.S., Namovic M., Jacobs I.C., Meyer M.D., Decker M.W. Reduced nicotinic receptor-mediated antinociception following in vivo antisense knock-down in rat. Brain Res. 871:2000;66-74.
5. Boyd R.T., Jacob M.H., McEachern A.E., Caron S., Berg D.K. Nicotinic acetylcholine receptor mRNA in dorsal root ganglion neurons. J Neurobiol. 22:1991;1-14.
6. Caggiula A.R., Epstein L.H., Perkins K.A., Saylor S. Different methods of assessing nicotine-induced antinociception may engage different neural mechanisms. Psychopharmacology. 122:1995;301-306.
7. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 53:1994;55-62.
8. Clarke P.B.S., Chaudieu I., El-Bixri H., Boksa P., Quik M., Esplin B.A., Čapek R. The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion. Br J Pharmacol. 111:1994;397-405.
9. Curzon P., Nikkel A.L., Bannon A.W., Arneric S.P., Decker M.W. Differences between the antinociceptive effects of the cholinergic channel activators A-85380 and (±)-epibatidine in rats. J Pharmacol Exp Ther. 287:1998;847-853.
10. Dirig D.M., Salami A., Rathbun M.L., Ozaki G.T., Yaksh T.L. Characterization of variables defining hindpaw withdrawal latency evoked by radiant thermal stimuli. J Neurosci Methods. 76:1997;183-191.
11. Gold M.S. Spinal nerve ligation: what to blame for the pain and why. Pain. 84:2000;117-120.
12. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
13. Iwamoto E.T. Antinociception after nicotine administration into the mesopontine tegmentum of rats: evidence for muscarinic actions. J Pharmacol Exp Ther. 251:1989;412-421.
14. A receptors in formalin-induced nociception in the rat. J Pharmacol Exp Ther. 282:1997;928-938.
15. Kauppila T., Kontinen V.K., Pertovaara A. Influence of spinalization on spinal withdrawal reflex responses varies depending on the submodality of the test stimulus and the experimental pathophysiological condition in the rat. Brain Res. 797:1998;234-242.
16. Kesingland A.C., Gentry C.T., Panesar M.S., Bowes M.A., Vernier J.-M., Cube R., Walker K., Urban L. Analgesia profile of the nicotinic acetylcholine receptor agonist, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain. Pain. 86:2000;113-118.
17. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 50:1992;355-363.
18. Lee B.H., Park S.-H., Won R., Park Y.G., Sohn J.-H. Antiallodynia effects produced by stimulation of the periaqueductal gray matter in a rat model of neuropathic pain. Neurosci Lett. 291:2000;29-32.
19. Liu C.-N., Wall P.D., Ben-Dor E., Michaelis M., Amir R., Devor M. Tactile allodynia in the absence of C-fiber activation: altered firing properties of DRG neurons following spinal nerve injury. Pain. 85:2000;503-521.
20. Lyu Y.S., Park S.K., Chung K., Chung J.M. Low dose of tetrodotoxin reduces neuropathic pain behaviors in an animal model. Brain Res. 871:2000;98-103.
21. Marubio L.M., de Mar Arroyo-Jimenez M., Cordero-Erausquin M., Léna C., Le Novère N., de Kerchove d'Exaerde A., Huchet M., Damaj M.I., Changeux J.-P. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature. 398:1999;805-810.
22. Millan M.J. The induction of pain: an integrative review. Prog Neurobiol. 57:1999;1-164.
23. Ninkovic M., Hunt S.P. α-Bungarotoxin binding sites on sensory neurons and their axonal transport in sensory afferents. Brain Res. 272:1983;57-60.
24. Omote K., Kawamata T., Kawamata M., Namiki A. Formalin-induced nociception activates a monoaminergic descending inhibitory system. Brain Res. 814:1998;194-198.
25. Ossipov M.H., Sun H., Malan T.P. Jr., Lai J., Porreca F. Mediation of spinal nerve injury induced tactile allodynia by descending facilitatory pathways in the dorsolateral funiculus in rats. Neurosci Lett. 290:2000;129-132.
26. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1997;Academic Press, New York, NY.
27. Proudfit H.K., Hammond D.L. Alterations in nociceptive threshold and morphine-induced analgesia produced by intrathecally administered amine antagonists. Brain Res. 218:1981;393-399.
28. Puttfarcken P.S., Manelli A.M., Arneric S.P., Donnelley-Roberts D.L. Evidence for nicotinic receptors potentially modulating nociceptive transmission at the level of the primary sensory neuron: studies with F11 cells. J Neurochem. 69:1997;930-938.
29. Rogers D.T., Iwamoto E.T. Multiple spinal mediators in parenteral nicotine-induced antinociception. J Pharmacol Exp Ther. 267:1993;341-349.
30. Rueter L.E., Meyer M.D., Decker M.W. Spinal mechanisms underlying A-85380-induced effects on acute thermal pain. Brain Res. 872:2000;93-101.
31. Sheen K., Chung J.M. Signs of neuropathic pain depend on signal from injured nerve fibers in a rat model. Brain Res. 610:1993;62-68.
32. Sindrup S.H., Jensen T.S. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain. 83:1999;389-400.
33. 2 nicotinic acetylcholine receptor ligand. Neuropharmacology. 35:1996;725-734.
34. Sung B., Na H.S., Kim Y.I., Yoon Y.W., Han H.C., Nahm S.H., Hong S.K. Supraspinal involvement in the production of mechanical allodynia by spinal injury in rats. Neurosci Lett. 246:1998;117-119.
35. Xu M., Kontinen V.K., Kalso E. Endogenous noradrenergic tone controls symptoms of allodynia in the spinal nerve ligation model of neuropathic pain. Eur J Pharmacol. 366:1999;41-45.
36. Zhang J.-M., Li H., Brull S.J. Perfusion of the mechanically compressed lumbar ganglion with lidocaine reduces mechanical hyperalgesia and allodynia in the rat. J Neurophysiol. 84:2000;798-805.